CClinicalTrials.gg
CompletedNCT04234230SELMAUpdated Nov 6, 2020

Improved Self-management for Patients on Ventricular Assist Device (VAD)

An observational study in Ventricular Assist Device, Self-management and Psychological Factors, sponsored by University of Freiburg. Completed at 4 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-11-06.

Sponsored by University of Freiburg · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
393
Ages
18 Years and older
Sex
All
01

Study summary

The number of patients with end-stage heart disease requiring the implantation of ventricular assist devices (VAD) is steadily increasing. Living with a VAD exposes the patients to multiple challenges and the need to learn complex self-management skills. Inadequate self-management can lead to serious complications (e.g. bleeding or wound infections) and impair the psychosocial outcome. This study aims to provide multi-centered actual analysis of self-management capabilities as well as analyzing moderating predictors in VAD patients through standardized prevalence assessment. Using a cross-sectional design, this prevalence study will be conducted at four established German heartcenters (Freiburg, Berlin, Bad Oeynhausen, Leipzig). VAD-patients are questioned about their self-management skills using standardized Patient-reported outcome (PRO) measures. Secondary PRO measures include health-related quality of life, symptoms of anxiety and depression, post-traumatic stress symptoms, social support, and changed body-image. Relevant complications (bleeding, wound infections, thromboembolic neurological events) are taken from the patient records. Based on a conservative sample size estimation inclusion of 450 patients is envisioned. The expected results may contribute to an improved assessment of the current situation in terms of self-management skills and needs for curricular training concepts and psychosocial concomitant therapy. Long-term, the study results contribute to improve the health care for long-term VAD patients.

Read the detailed description

The number of patients with end-stage heart disease requiring the implantation of ventricular assist devices (VAD) is steadily increasing. Due to advanced compensatory technological developments, VAD support has been established as a recognized therapy concept for the long-term care of those affected. Indications include a multi-year bridging therapy (up to 10 years) and increasingly a destination therapy. The Euromacs Register published the second report in 2018 and reported 2,947 registered VAD implantations in 2016 (+257 percent). Euromacs further points to a rising trend and demand for the use of VAD systems. In Germany, an increase of VAD implantation by 36.6 percent has been reported since 2011. The position paper of the German Society of Cardiology (2016) points to the fact that the range of indications for VAD implantation for patients with chronic heart disease will continue to change. The ISHLT Guideline (International Society for Heart and Lung Transplantation), published in 2018, calls for psychosocial care and standardized self-management skills for patients before, during, and in the long-term after VAD implantation. This is currently being implemented inconsistently in terms of structure and quality in German cardiac centers. After VAD implantation, patients and their relatives must be able to follow a complex therapeutic regimen. They need comprehensive knowledge as well as self-management skills for the safe management of everyday life in a domestic setting. These self-management capabilities include the so-called device handling (for example dealing with the technical equipment including battery replacement and controller monitoring), to perform the wound care of the driveline, to carry out anticoagulation measurements and adapted revenues of oral anticoagulant, to take further medication, to monitor vital signs (for example blood pressure, temperature) and, in the case of symptoms, to take adequate measures to prevent further complications (for example prompt information from the heart center on the onset of symptoms). In addition, lifestyle changes are an essential part of the success of long-term therapy. This requires a sufficient degree of self-management ability and mental stability. In addition, it is important to emotionally accept the dependence of a device on the heart, the changed body image, to cope with fears of (real potential) malfunctions and complications and to build up a subjective quality of life with a constant, visible and tangible companion at heart. The mental health of all those affected is considered to be in need of observation, although there is currently no reliable prevalence data on mental disorders. In a first survey in 2006, 64% had at least one psychologically / psychiatric treatment requiring diagnosis. All this shows, the challenges VAD patients have to face are complex. Thus, this study aims to provide multi-centered actual analysis of self-management capabilities as well as analyzing moderating predictors in VAD patients through standardized PRO prevalence assessment. The prevalence survey should be conducted in all outpatients (at least 3 months up to a maximum of 3 years at the VAD) in four established German cardiac centers (Freiburg, Berlin, Bad Oeynhausen, Leipzig). The study focuses on those involved in outpatient care, as they had to integrate the VAD into their daily lives after implantation and are able to report deficits, resources and needs on the basis of their experience of self-management. As an assessment instrument a standardized PRO measure was chosen to identify self-management skills and needs. Secondary PRO measures include health-related quality of life, symptoms of anxiety, depression and post-traumatic stress, as well as social support. Relevant complications (bleeding, wound infections, thromboembolic neurological events) are taken from the patient records. Based on a conservative sample size estimation inclusion of 450 patients is envisioned. The expected results may contribute to an improved assessment of the current situation in terms of self-management skills and needs for curricular training concepts and psychosocial concomitant therapy. Long-term, the study results contribute to improve the health care for long-term VAD patients. The study is planned to continue in a second and third phase to develop and test a standardized self-management care for VAD patients in Germany.

02

Conditions studied

  • Ventricular Assist Device
  • Self-management
  • Psychological Factors

Keywords

  • Ventricular Assist Device
  • Self-management
  • Psychosocial Factors
03

In context

Lead sponsor

University of Freiburg is the lead sponsor of 27 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients implanted with a ventricular assist device in the outpatient setting of four heart centers in Germany (Freiburg, Berlin, Bad Oeynhausen and Leipzig).

Inclusion criteria

  • Outpatient at the respective heart center
  • Living in a home environment
  • On device between 3 months and 3 years
  • 18 years and older
  • No contraindications (e.g. cognitive, language)
  • Signed Informed Consent

Exclusion criteria

Exclusion Criteria:

  • In-patient stay
  • Not living in a home environment (e.g. assisted living)
  • On device less than 3 months or more than 3 years
  • Underage
  • Contraindications (e.g. cognitive, language)
  • No signed Informed Consent
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
393 participants (actual)
Patient registry
No

Groups and cohorts

  • VAD Patients

    Patients with implanted ventricular assist device in the outpatient setting

    Other: Prevalence Survey

Interventions

  • OtherPrevalence Survey

    Questionnaire survey on self-management

06

What researchers measure

Primary outcomes

  1. Self-management Skills

    As an assessment instrument a standardized PRO measure was chosen to identify self-management skills and needs.

    Time frame: October 2019 till January 2020

Secondary outcomes

  1. Health-related Quality of Life

    The experienced health-related quality of life of the participants measured with a selfassessment questionnaire (QoL-VAD, KCCQ).

    Time frame: October 2019 till January 2020

  2. Social Support

    The experienced social support of the participants measured with a selfassessment questionnaire (F-SozU).

    Time frame: October 2019 till January 2020

  3. Symptoms of Anxiety

    Symptoms of anxiety measured via screening tool (HADS).

    Time frame: October 2019 till January 2020

  4. Symptoms of Depression

    Symptoms of depression measured via screening tool (HADS, PHQ-9).

    Time frame: October 2019 till January 2020

  5. Symptoms of Posttraumatic Stress Disorder

    Symptoms of posttraumatic stress disorder measured via screening tool (PTSD-7).

    Time frame: October 2019 till January 2020

Other outcomes

  1. Comorbidities

    Relevant comorbidities (e.g. Diabetes, Hypertension, psychic comorbidities) will be taken from the medical record of the participants.

    Time frame: October 2019 till January 2020

  2. VAD Type

    Information on implanted VAD type (HVAD, HMIII or other) will be taken from the medical record of the participants.

    Time frame: October 2019 till January 2020

  3. New York Heart Association (NYHA) classification

    Information on New York Heart Association (NYHA) classification of the participants will be taken from their medical record.

    Time frame: October 2019 till January 2020

  4. VAD-related complications

    Emerged VAD-related complications (e.g. neurologic events, major bleeding events, infections) will be taken from the patients' medical record.

    Time frame: October 2019 till January 2020

07

Study locations

4 sites
  • University Heart Center Freiburg
    Freiburg, Baden-Württemberg 79110, Germany
  • Heart and Diabetes Center North Rhine-Westphalia
    Bad Oeynhausen, North Rhine-Westphalia 32545, Germany
  • Leipzig Heart Center
    Leipzig, Sachsen 04289, Germany
  • German Heart Center
    Berlin, 13353, Germany
08

References and documents

Publications

  • Kugler C, Spielmann H, Seemann M, Lauenroth V, Wacker R, Albert W, Spitz-Koeberich C, Semmig-Koenze S, von Cube M, Tigges-Limmer K. Self-management for patients on ventricular assist device support: a national, multicentre study: protocol for a 3-phase study. BMJ Open. 2021 May 5;11(5):e044374. doi: 10.1136/bmjopen-2020-044374. PubMed 33952544 ↗
  • Spielmann H, Seemann M, Friedrich N, Tigges-Limmer K, Albert W, Semmig-Konze S, Spitz-Koberich C, Kugler C. Self-management with the therapeutic regimen in patients with ventricular assist device (VAD) support - a scoping review. Heart Lung. 2021 May-Jun;50(3):388-396. doi: 10.1016/j.hrtlng.2021.01.019. Epub 2021 Feb 20. PubMed 33621837 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04234230
Lead sponsor
University of Freiburg
Collaborators
University Heart Center Freiburg - Bad Krozingen, Heart and Diabetes Center North-Rhine Westfalia, German Heart Center, Heart Center Leipzig - University Hospital
Responsible party
Christiane Kugler (Professor Doctor. rer. biol. hum., University of Freiburg) — Principal investigator
First posted
Jan 21, 2020
Start date
Oct 1, 2019
Primary completion
Aug 31, 2020
Completion
Sep 30, 2020
Last update
Nov 6, 2020

Study contacts

Christiane Kugler, Prof. Dr.
study director · University of Freiburg
Christiane Kugler, Prof. Dr.
principal investigator · University of Freiburg

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion